At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
fondaparinuxdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospektive Studie zu Patientinnen, Die pränatal, Perinatal Oder Postnatal Prophylaktisch Oder Therapeutisch Mit Fondaparinux Behandelt Wurden
In Brief
An observational study evaluating fondaparinux for Thromboembolism and Venous Thromboembolism. Completed, enrolled 120 participants across 7 sites.
Detailed Summary
The objective of this retrospective study is to gather information about how fondaparinux is used pre-, peri- and/or postpartum for both the prophylaxis and treatment of venous thromboembolism (VTE) in order to fill an information gap concerning the off-label use of fondaparinux during pregnancy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsThromboembolism, Venous Thromboembolism
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 2009
Enrollment StartMar 2010
Primary CompletionJul 2010
TodayJul 2026
First PostedOct 30, 2009
Enrollment StartMar 1, 2010
Primary CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 16.7 years ago
Interventions
fondaparinuxdrug
fondaparinux